Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
about
Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalitiesTumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage ResponseDysregulation of ubiquitin ligases in cancerTumor suppressor and hepatocellular carcinomaCooperation between NRF-2 and YY-1 transcription factors is essential for triggering the expression of the PREPL-C2ORF34 bidirectional gene pair.Analysis of gene order conservation in eukaryotes identifies transcriptionally and functionally linked genes.Role of an ER stress response element in regulating the bidirectional promoter of the mouse CRELD2 - ALG12 gene pair.PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.Genetic determinants at the interface of cancer and neurodegenerative disease.Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.DNA methylation: its role in cancer development and therapy.Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8.Role of gene-expression profiling in chronic myeloid leukemia.Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.An emerging role of PARK2 in cancer.Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma.Androgen receptor CpG island methylation status in human leukemia cancer cells.Response to rotenone is glucose-sensitive in a model of human acute lymphoblastic leukemia: involvement of oxidative stress mechanism, DJ-1, Parkin, and PINK-1 proteins.Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.Parkin induces upregulation of 40S ribosomal protein SA and posttranslational modification of cytokeratins 8 and 18 in human cervical cancer cells.Parkin gene alterations in ovarian carcinoma from northern Indian population.Genome wide DNA-profiling of HIV-related B-cell lymphomas.Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.Vertebrate food products as a potential source of prion-like α-synuclein.No differential DNA methylation of PARK2 in brain of Parkinson's disease patients and healthy controls.Epigenetics in Parkinson's Disease.Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.Genetics and epigenetics of Parkinson's disease.Mitochondrial Regulation by PINK1-Parkin Signaling
P2860
Q27023811-02192F56-8185-4AEE-9D95-B5F38C9A4243Q28070247-03E5684E-C75C-42E5-8622-BE933D16C49EQ28086796-D0E310B7-D70C-477C-926E-E5CD79D10AF3Q28389231-9AF314C7-2AD0-440D-8E2D-BF0347DC164DQ33477999-19E7DE91-5F8B-4CB2-9416-B82343A77C95Q33586232-53082B84-4718-4FCF-8CD5-99D4B1C26114Q33755518-EA84D258-551A-49C8-8409-4E60A3EC0C08Q34093865-93EE6F68-D07F-497F-B1D9-84A9A43280A4Q34422582-298A695D-0EFC-4292-AB32-71C724798BC7Q36730935-FCA92739-E6C1-41CF-A282-72212B826E92Q36823704-7F6BCF2B-C254-4451-BB8A-B7A2F680E020Q36871702-D926B08B-15A5-4664-A99D-4BDCDFD7B7B4Q36986433-E83BC579-1106-4BB2-8651-39D2D664AD5BQ37282218-A12AC350-37D2-47E4-A8DD-FD5B4AA19C22Q37810111-E69B68BA-4C3D-4F50-802F-B4995C9ABB7EQ38021865-162260AD-A9C5-4ECE-B905-16F692695202Q38168127-18F92704-9589-4311-80B1-2EF8A1B743ADQ38709886-10CB5EC8-7194-4173-9929-267DC6AF9845Q39880790-ACC278F6-C2A7-4C8C-9E5A-5B3A09A1A9BAQ40031083-9E554E86-AF4D-47FB-B9C8-367620FDD01FQ42077959-E9A365B9-2929-45BC-9D30-C47528F813BAQ42273308-91033B87-10E9-425C-A07B-A51149DDD7E6Q44281189-AD85D471-08FA-43F7-A34D-431F5FFEAF83Q44644345-2EE48C18-35C3-4FDB-ABAA-6C28717EB9E9Q45923538-2806435F-46EC-4C70-93B1-12FDDF1A035AQ46252338-175ADDC5-9015-4D6B-AB25-C51D4778328CQ46699534-6C0BD369-F854-4735-957B-E6DBFFBE9A91Q47320399-E46D72CD-0CE5-4B24-8370-6D55CB5A3EE1Q48593906-901247B4-65BC-4748-8558-99D6829667C4Q53375184-242D742A-67BB-406F-BE05-3C4512BF4482Q58905388-725DEBAC-EABE-4C84-9F2D-B1E2337C794B
P2860
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@ast
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@en
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@nl
type
label
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@ast
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@en
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@nl
prefLabel
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@ast
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@en
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Abnormal methylation of the co ...... and chronic myeloid leukemia.
@en
P2093
Anabel Heiniger
Antonio Jiménez-Velasco
Antonio Torres
Cristina Montiel-Duarte
Felipe Prósper
Idoya Lahortiga
Iria Vázquez
John D Minna
José Román-Gómez
Leire Garate
P2860
P304
P356
10.1002/IJC.21584
P577
2006-04-01T00:00:00Z